Hypotension After First-Dose ACE Inhibitor Administration in Heart Failure—Should Doctors Stop Worrying? Willem J. Remme Editorial Board Pages: 475 - 477
Heart Function Challenged with β-Receptor Agonism or Antagonism in a Heart Failure Model Benny WashingtonKaryn ButlerJudith K. Gwathmey OriginalPaper Pages: 479 - 486
Prior Calcium Channel Blockade and Short-Term Survival Following Acute Myocardial Infarction Richard W ParsonsJoseph HungMichael ST Hobbs OriginalPaper Pages: 487 - 492
Effect of Diltiazem on Cardiac Function Assessed by Echocardiography and Neurohumoral Factors After Reperfused Myocardial Infarction Without Congestive Heart Failure Norimasa MakiMinoru YoshiyamaJunichi Yoshikawa OriginalPaper Pages: 493 - 499
A Comparative Study of the First Dose Hypotensive Effects of Captopril and Perindopril in Patients with Heart Failure Portuguese Community Hospital Study Group on Heart Failure OriginalPaper Pages: 501 - 506
Apoptosis in Cardiac Disease—What is it—How Does it Occur Michael NeussMichael T. CrowEdward G. Lakatta OriginalPaper Pages: 507 - 523
Neurohormones, Cytokines and Programmed Cell Death in Heart Failure: A New Paradigm for the Remodeling Heart Marco ValgimigliSalvatore CurelloRoberto Ferrari OriginalPaper Pages: 529 - 537
Apoptosis in Cardiovascular Remodeling—Effect of Medication Denis deBloisSergei N. OrlovPavel Hamet OriginalPaper Pages: 539 - 545
Apoptosis—New Opportunities for Novel Therapeutics for Heart Diseases Giora Z. Feuerstein OriginalPaper Pages: 547 - 551
Apoptosis in Cardiac Disease: From Basics to Clinics—An Editorial Commentary Martin Paul OriginalPaper Pages: 553 - 554
The Use of Simvastatin in Analbuminaemia Lesley Jean BurgessAdrian David Marais Legacy Pages: 555 - 558
Optimizing the Prescription of Statins After an Acute Coronary Syndrome: The Influence of Coronary Angioplasty and Total Cholesterol Levels Jean FerrièresNicolas DanchinJean-Pierre Cambou Letter to the Editor Pages: 559 - 560